Neil Mariados, MD
Therapeutic Radiology · Syracuse, NYNPI 1043204621
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $155,514 of the $191,375 with a category attached, or 81.3%. Palette Life Sciences, Inc. accounts for 78.4% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2023 at $114,242 and has fallen 99.9% since, to $78 in 2025. Among therapeutic radiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 129 payments — averaging $1483.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Palette Life Sciences, Inc.$150K
- Bayer$14K
- Boston Scientific$13K
- Janssen Scientific Affairs, LLC$8K
- Myriad Genetic Laboratories, Inc.$3K
- Blue Earth Diagnostics$875
- plus $3K from 18 others
Across 8 payments — averaging $184,759 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Palette Life Sciences, Inc.$1.5M
What the payments were for
- Consulting fees$155,51481%
- Speaking & faculty fees$12,7847%
- Travel & lodging$3,8912%
- Food & beverage$5,5343%
- Education$4640%
- Ownership interest$5,1913%
- Other$7,9974%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Palette Life Sciences, Inc. | 50 | $150,126 |
| Bayer | 15 | $13,742 |
| Boston Scientific | 5 | $13,311 |
| Janssen Scientific Affairs, LLC | 3 | $7,600 |
| Myriad Genetic Laboratories, Inc. | 6 | $2,846 |
| Blue Earth Diagnostics | 1 | $875 |
| Johnson & Johnson | 5 | $723 |
| Astellas Pharma US Inc | 9 | $646 |
| Dendreon Pharmaceuticals LLC | 6 | $373 |
| Siemens Medical Solutions USA, Inc. | 2 | $170 |
| AstraZeneca | 8 | $157 |
| Novocure Inc. | 3 | $153 |
| Elekta, Inc. | 2 | $121 |
| Tolmar Pharmaceuticals, Inc. | 2 | $120 |
| Pfizer | 1 | $100 |
| Foundation Medicine, Inc. | 1 | $79 |
| Neotract Inc. | 1 | $60 |
| AbbVie | 3 | $52 |
| Urogen Pharma, Inc. | 1 | $31 |
| Myovant Sciences Inc. | 1 | $24 |
| Accord Healthcare, Inc. | 1 | $21 |
| Merck | 1 | $18 |
| Accuray Incorporated | 1 | $13 |
| Sun Pharmaceutical Industries Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$12,016
- Xofigo$11,683
- Erleada$3,814
- Prolaris$2,450
- Nubeqa$1,708
- Axumin$875
- ELEKTA MEDICAL LINEAR ACCELERATOR$405
- BRACAnalysis CDx$350
- PROVENGE$299
- XTANDI$203
- VariSeed 9.0$145
- GENERAL BPH$123
- Optune$111
- Clarity$101
How this compares
$191,375 in reported general payments places this provider in the 95th percentile of 24 therapeutic radiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other therapeutic radiology in Syracuse
- Stephen RandallSyracuse$267
- Christopher CraneNew York$70K
- Wesley TalcottNew York$9K
- Jerry LiuNew York$5K
- Keyur MehtaBronx$4K
- Jana FoxBronx$2K
- Sung LeeNew York$1K
- James ButlerBrooklyn$1K
- Aimee GallantBrooklyn$750
- Meri AtanasRochester$507
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.